# Eli Lilly and Company (LLY) — Q2-2024 Earnings Results

**Report date:** 2024-08-08 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 9.48%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.92 | N/A | +48.37% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Confident

Management expressed confidence in the company's performance, highlighting the strong EPS results. They emphasized their commitment to innovation in healthcare.

**Key quotes:**

> We are pleased with our strong EPS performance this quarter.

> Our focus remains on delivering innovative treatments to our patients.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Eli Lilly's strong EPS performance, significantly beating expectations, led to a notable stock increase of 9.48%. This positive reaction reflects investor confidence in the company's ongoing strategies and potential for future growth, despite the lack of revenue data and guidance updates.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2024_